NYSE:MDT

Medtronic Stock Forecast, Price & News

$123.23
-1.98 (-1.58 %)
(As of 06/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$123.19
$124.36
50-Day Range
$121.79
$131.50
52-Week Range
$87.68
$132.30
Volume5.82 million shs
Average Volume4.68 million shs
Market Capitalization$166.12 billion
P/E Ratio46.33
Dividend Yield1.85%
Beta0.79
30 days | 90 days | 365 days | Advanced Chart
Receive MDT News and Ratings via Email

Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.


Medtronic logo

About Medtronic

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; electrosurgical hardware and instruments, and mesh fixation devices; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; colorectal surgeons; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

2.39 out of 5 stars

Medical Sector

11th out of 2,097 stocks

Electromedical Equipment Industry

1st out of 62 stocks

Analyst Opinion: 2.4Community Rank: 3.3Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Medtronic (NYSE:MDT) Frequently Asked Questions

Is Medtronic a buy right now?

23 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last twelve months. There are currently 4 hold ratings and 19 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Medtronic stock.
View analyst ratings for Medtronic
or view top-rated stocks.

What stocks does MarketBeat like better than Medtronic?

Wall Street analysts have given Medtronic a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Medtronic wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Medtronic's next earnings date?

Medtronic is scheduled to release its next quarterly earnings announcement on Tuesday, August 24th 2021.
View our earnings forecast for Medtronic
.

How were Medtronic's earnings last quarter?

Medtronic plc (NYSE:MDT) issued its quarterly earnings results on Wednesday, May, 26th. The medical technology company reported $1.50 EPS for the quarter, beating the consensus estimate of $1.42 by $0.08. The medical technology company earned $8.19 billion during the quarter, compared to the consensus estimate of $8.13 billion. Medtronic had a trailing twelve-month return on equity of 11.82% and a net margin of 11.98%. The company's quarterly revenue was up 36.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.58 earnings per share.
View Medtronic's earnings history
.

How has Medtronic's stock been impacted by COVID-19 (Coronavirus)?

Medtronic's stock was trading at $92.44 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MDT stock has increased by 33.3% and is now trading at $123.23.
View which stocks have been most impacted by COVID-19
.

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic announced a quarterly dividend on Thursday, May 27th. Investors of record on Friday, June 25th will be given a dividend of $0.63 per share on Friday, July 16th. This represents a $2.52 dividend on an annualized basis and a yield of 2.04%. The ex-dividend date is Thursday, June 24th. This is an increase from Medtronic's previous quarterly dividend of $0.58.
View Medtronic's dividend history
.

Is Medtronic a good dividend stock?

Medtronic pays an annual dividend of $2.32 per share and currently has a dividend yield of 1.85%.
View Medtronic's dividend history.

What guidance has Medtronic issued on next quarter's earnings?

Medtronic updated its FY 2022 earnings guidance on Tuesday, June, 15th. The company provided earnings per share (EPS) guidance of $5.600-5.750 for the period, compared to the Thomson Reuters consensus estimate of $5.720. The company issued revenue guidance of -.

What price target have analysts set for MDT?

23 brokers have issued 1 year price targets for Medtronic's stock. Their forecasts range from $115.00 to $153.00. On average, they anticipate Medtronic's stock price to reach $135.48 in the next year. This suggests a possible upside of 9.9% from the stock's current price.
View analysts' price targets for Medtronic
or view top-rated stocks among Wall Street analysts.

Who are Medtronic's key executives?

Medtronic's management team includes the following people:
  • Mr. Geoffrey Straub Martha, CEO & Chairman (Age 51, Pay $1.68M)
  • Ms. Karen L. Parkhill, Exec. VP & CFO (Age 56, Pay $1.81M)
  • Mr. Bradley E. Lerman, Sr. VP, Gen. Counsel & Corp. Sec. (Age 65, Pay $1.74M)
  • Mr. Mark Ploof, Sr. VP of Global Operations and Bus. Services
  • Dr. Richard E. Kuntz, Sr. VP & Chief Medical and Scientific Officer (Age 64)
  • Mr. Sean Lennon, Chief Information Officer
  • Mr. Ryan Weispfenning, VP of Investor Relations
  • Ms. Marguerite Copel, PR & Interim Chief Communications Officer
  • Ms. Carol A. Surface, Sr. VP & Chief HR Officer (Age 55)
  • Mr. Sean M. Salmon, EVP, Pres of Diabetes Operating Unit & EVP & Pres of Cardiovascular Portfolio (Age 55)

What is Omar S. Ishrak's approval rating as Medtronic's CEO?

1,925 employees have rated Medtronic CEO Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among Medtronic's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Medtronic's key competitors?

What other stocks do shareholders of Medtronic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), The Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), The Home Depot (HD) and Walmart (WMT).

What is Medtronic's stock symbol?

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Who are Medtronic's major shareholders?

Medtronic's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (7.92%), Massachusetts Financial Services Co. MA (3.55%), Lazard Asset Management LLC (1.79%), Price T Rowe Associates Inc. MD (1.63%), Geode Capital Management LLC (1.59%) and Bank of New York Mellon Corp (1.43%). Company insiders that own Medtronic stock include Bradley E Lerman, Brett A Wall, Carol A Surface, Hoedt Rob Ten, Hooman Hakami, John R Liddicoat, Karen L Parkhill, Michael J Coyle, Omar Ishrak, Richard H Anderson, Richard Kuntz and Robert John White.
View institutional ownership trends for Medtronic
.

Which institutional investors are selling Medtronic stock?

MDT stock was sold by a variety of institutional investors in the last quarter, including Vontobel Asset Management Inc., Pendal Group Limited, Massachusetts Financial Services Co. MA, Amundi Asset Management US Inc., Schafer Cullen Capital Management Inc, Bank of Montreal Can, Nordea Investment Management AB, and CIBC World Markets Inc.. Company insiders that have sold Medtronic company stock in the last year include Bradley E Lerman, Brett A Wall, Carol A Surface, Hoedt Rob Ten, John R Liddicoat, Karen L Parkhill, Omar Ishrak, and Robert John White.
View insider buying and selling activity for Medtronic
or view top insider-selling stocks.

Which institutional investors are buying Medtronic stock?

MDT stock was bought by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Price T Rowe Associates Inc. MD, Fred Alger Management LLC, Cullen Capital Management LLC, Redmile Group LLC, Royal Bank of Canada, Envestnet Asset Management Inc., and DekaBank Deutsche Girozentrale. Company insiders that have bought Medtronic stock in the last two years include Omar Ishrak, and Richard H Anderson.
View insider buying and selling activity for Medtronic
or or view top insider-buying stocks.

How do I buy shares of Medtronic?

Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medtronic's stock price today?

One share of MDT stock can currently be purchased for approximately $123.23.

How much money does Medtronic make?

Medtronic has a market capitalization of $166.12 billion and generates $30.12 billion in revenue each year.

How many employees does Medtronic have?

Medtronic employs 90,000 workers across the globe.

When was Medtronic founded?

Medtronic was founded in 1949.

What is Medtronic's official website?

The official website for Medtronic is www.medtronic.com.

Where are Medtronic's headquarters?

Medtronic is headquartered at 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02.

How can I contact Medtronic?

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at 353-1438-1700 or via email at [email protected]


This page was last updated on 6/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.